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Background: We previously demonstrated embryotrophic actions of maternal (oocyte-derived) follistatin during
bovine early embryogenesis. Classical actions of follistatin are attributed to inhibition of activity of growth factors
including activins and bone morphogenetic proteins (BMP). However, temporal changes in BMP mRNA in early
bovine embryos and the effects of exogenous BMP on embryo developmental progression are not understood. The
objectives of present studies were to characterize mRNA abundance for select BMP, BMP receptors and BMP
receptor associated SMADs during bovine oocyte maturation and early embryogenesis and determine effects of
addition of exogenous BMP protein on early development.
Methods: Relative abundance of mRNA for BMP2, BMP3, BMP7, BMP10, SMAD1, SMAD5, ALK3, ALK6, ALK2, BMPR2,
ACVR2A and ACVR2B was determined by RT-qPCR analysis of germinal vesicle (GV) and in vitro matured metaphase
II (MII) oocytes and in vitro produced embryos collected at pronuclear, 2-cell (C), 4C, 8C, 16C, morula and blastocyst
stages. Effects of addition of recombinant human BMP2 (0, 1, 10 and 100 ng/ml) during initial 72 h of embryo
culture on early cleavage (within 30 h post insemination), total cleavage, development to 8C-16C and blastocyst
stages and blastocyst mRNA abundance for markers of inner cell mass (NANOG) and trophectoderm (CDX2) were
also determined.
Results: Abundance of mRNA for BMP2, BMP10, SMAD1, SMAD5, ALK3, ALK2, BMPR2 and ACVR2B was elevated in MII
oocytes and/or pronuclear stage embryos (relative to GV) and remained elevated through the 8C -16C stages,
whereas BMP3, BMP7 and ALK2 mRNAs were transiently elevated. Culture of embryos to the 8C stage in the
presence of α-amanitin resulted in increased abundance for all of above transcripts examined relative to untreated
8C embryos. Effects of addition of exogenous BMP2 on early cleavage rates and rates of development to 8C-16C
and blastocyst stages were not observed, but BMP2 treatment increased blastocyst mRNA for CDX2 and NANOG.
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Conclusions: Abundance of maternally derived mRNAs for above BMP system components are dynamically
regulated during oocyte maturation and early embryogenesis. Exogenous BMP2 treatment does not influence
progression to various developmental endpoints, but impacts characteristics of resulting blastocysts. Results support
a potential role for BMPs in bovine early embryogenesis.
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Oocyte developmental competence was defined by Sirard
et al. [1] as the capacity of the oocyte to resume meiosis,
cleave after fertilization, help promote embryonic develop-
ment and implantation, and bring a pregnancy to term in
good health [1]. Our previous studies support a positive
functional role for maternal (oocyte-derived) follistatin in
bovine oocyte competence. Follistatin mRNA is positively
associated with developmental competence in two distinct
bovine models of egg quality [2,3]. Furthermore, follistatin
supplementation during the first 72 h of bovine embryo
culture (until embryonic genome activation) enhanced
proportion of embryos that cleaved early and proportion
of embryos developing to the blastocyst stage in a dose
dependent fashion [3]. Follistatin treatment also increased
total blastocyst cell numbers specifically through an in-
crease in trophectoderm (TE) cells, with no effect on
numbers of inner cell mass (ICM) cells and increased
blastocyst mRNA for the TE specific transcription factor
CDX2 [3]. We also observed similar effects of follistatin
treatment on early cleavage and rates of development to
blastocyst stage for rhesus monkey embryos [4], demon-
strating potential translational relevance of results from
the bovine model system. However, the mechanisms re-
sponsible for stimulatory effects of follistatin on multiple
indices of bovine early embryonic development to date
still remain elusive.
Follistatin was initially classified as a high affinity bind-
ing protein inhibiting activin action [5]. However, stimu-
latory effects of exogenous activin treatment on early
cleavage and blastocyst rates for bovine embryos were
also observed suggesting a potential alternative mechan-
ism of follistatin action [3]. Follistatin can also bind and
regulate activity of multiple additional TGFβ superfamily
members including BMPs [6-8]. A prominent role for
BMPs in regulation of patterning of early embryos has
been described [9]. Furthermore, BMPs have been impli-
cated in regulation of trophoblast differentiation in hu-
man embryonic stem cells [10]. However, less is known
about their role during preimplantation embryonic de-
velopment, particularly in farm species.
In this study, we investigated temporal changes in
mRNA abundance for multiple BMP, BMP receptors
and their associated SMADs in bovine oocytes andembryos and the source of such transcripts (maternal
versus embryonic) in bovine embryos coincident with em-
bryonic genome activation. We also determined the effect
of exogenous BMP2 on multiple endpoints relevant to bo-
vine early embryonic developmental progression. Results
demonstrate dynamic regulation of maternal mRNAs for
BMP system components during bovine early embryonic
development and effects of exogenous BMP2 treatment
on indices of cell lineage determination in bovine blasto-
cysts. Results also suggest embryotropic actions of follista-
tin on bovine early embryogenesis are likely not mediated
by antagonism of BMP2 signaling.Methods
Oocyte collection, in vitro maturation, in vitro fertilization
and embryo culture
Bovine oocytes used for all described experiments were
obtained from ovaries harvested at a local abattoir. As-
piration and in vitro maturation of oocytes, in vitro
fertilization and culture of embryos was performed as
previously described [3]. Cumulus-oocyte complexes
(aspirated from 2–7 mm visible follicles) with > 4
compact cumulus cell layers and homogeneous cyto-
plasm were matured in TCM 199 [supplemented with
0.2 mM sodium pyruvate, 5 mg/ml gentamicin sulfate,
6.5 mM L-glutamine, 156 nM bovine LH (Sioux Bio-
chemical, Sioux Center, Iowa), 15.6 nM bovine FSH
(Sioux Biochemical), 3.67 nM 17β-estradiol and 10% v/v
defined FBS (Hyclone, Logan, UT)] for 24 h at 38.5°C,
5% CO2 in air with maximum humidity. For in vitro
fertilization, matured oocytes were washed and co-
incubated with sperm for 20 h in fertilization medium
(114 mM NaCl, 25 mM NaHCO3, 3.2 mM KCl, 0.34 mM
NaH2PO4, 0.183 mM penicillin-G, 16.6 mM sodium lac-
tate, 0.5 mM MgCl2:6H2O, 2.7 mM CaCl2:2H2O, 0.2 mM
sodium pyruvate, 6 mg/ml BSA and 1.5 U of heparin) at
38.5°C, 5% CO2 in air with maximum humidity. After cu-
mulus cell removal, presumptive zygotes were washed and
cultured in potassium simplex optimization medium
(KSOM; EMD Millipore, Billerica MA) supplemented
with 0.3% BSA for 72 h. Embryos were then washed and
cultured in fresh KSOM medium supplemented with 0.3%
BSA and 10% FBS until day 7.
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Germinal vesicle (GV) and metaphase (MII) stage (oo-
cytes), pronuclear (PN), 2-cell (C), 4C, 8C, 16C, morula
and blastocyst stage embryos (n = 4 pools of 10 each),
were collected as we described previously [3,11]. For GV
and MII stage oocyte RNA samples, cumulus cells were
completely removed by hyaluronidase (0.1%) digestion
and repeated pipetting and denuded oocytes in groups
of 10 each were snap frozen in 100 μl lysis solution
(RNAqueous Micro Kit, Ambion Inc, Austin, TX) and
stored at −80°C until RNA isolation. Embryo samples
were also processed as described above in groups of 10
per sample per stage with PN embryos harvested at 20 h
post insemination (hpi), 2C embryos collected 33 hpi,
4C embryos 44 hpi, 8C embryos 52 hpi, 16C embryos 72
hpi, and morulas and blastocysts at 5 and 7 d post in-
semination respectively. 250 femtograms of polyadeny-
lated GFP RNA were added to each sample prior to
RNA extraction. After finishing RNA isolation and
cDNA synthesis, cDNA was diluted 1:5 and mRNA
quantification for BMP2, BMP3, BMP7, BMP10, ALK2,
ALK3, ALK6, BMPR2, ACVR2A, ACVR2B, SMAD1 and
SMAD5 mRNAs was performed in duplicate for each
sample by qPCR using our procedures reported previ-
ously [11]. Relative expression levels were calculated
using the ΔΔCT method with RPS18 as the housekeep-
ing gene [12], RPS18 mRNA abundance is very stable
across MII through 16C stages and then is increased in
later stages coincident with increase in cell numbers
(Additional file 1: Figure S1). Abundance of exogenous
control (GFP) RNA was also measured to account for
variation in RNA recovery and cDNA synthesis across
samples and exogenous GFP mRNA abundance was
similar (P > 0.2) across samples. Primer sequences and
fragment sizes for all transcripts measured are included
in Table 1 and PCR efficiencies for all primer sets were
between 90 and 103%.
Effect of transcriptional inhibition on BMP system mRNA
abundance
To determine the effects of inhibition of transcription
on mRNA abundance in in vitro derived embryos, pre-
sumptive zygotes were cultured in serum free KSOM
with 0.3% BSA with or without the addition of 50 μg/ml
α-amanitin (Sigma, St. Louis, MO). The 8C embryos
were then collected at 52 h post insemination (n = 4
pools of 10 embryos per group) and placed in lysis buffer
and snap frozen and stored as above until RNA isolation.
Half the RNA was subjected to reverse transcription
using oligo(dT) primers as described above for use in
quantification of polyadenylated transcripts for genes of
interest. The remaining RNA was transcribed using ran-
dom hexamers for quantification of adenylated anddeadenylated (total) transcripts for genes of interest. The
cDNA produced was subjected to qPCR for the BMP
system components as described above. Data were nor-
malized relative to abundance of endogenous control
(RPS18).
Effect of BMP2 supplementation on bovine embryo
developmental progression
To examine the effect of BMP2 supplementation on
early cleavage rate (assessed 30 hpi), rate of development
to 8C-16C stage (assessed 72 hpi), blastocyst rate
(assessed 7 d post insemination) and the abundance of
mRNA for the TE marker (CDX2) and ICM marker
(NANOG) in resulting blastocysts, presumptive zygotes
were cultured in KSOM medium supplemented with
0.3% BSA containing 0, 1, 10 or 100 ng/ml BMP 2 (30
presumptive zygotes per group, 4 replicates). The 8C-
16C stage embryos were then separated 72 h post
fertilization and cultured in fresh KSOM medium
(minus exogenous BMP2) supplemented with 0.3% BSA
and 10% FBS until d 7. Blastocysts were harvested at d 7
post fertilization (n = 4 pools of 5 blastocysts each per
treatment) and lysed and frozen as above until RNA iso-
lation and RT-qPCR analysis as described above.
Statistical analysis
All data were analyzed using one way ANOVA in SAS
followed by Fishers Protected Least Significant Differ-
ence Test to determine differences between means. For
embryo culture experiments, % data were arc-sin trans-
formed prior to analysis. Data are presented as mean ±
SEM.
Results and discussion
Temporal regulation of BMP mRNA abundance during
oocyte maturation and early embryogenesis
Transcriptome analysis of human oocytes indicates that
multiple key components of the TGFβ superfamily sig-
naling pathway are potentially active [13] and previous
studies support a functional role for TGFβ superfamily
members during bovine oocyte maturation and early
embryogenesis [3,14,15]. Over 20 members of the BMP
subfamily have been described [16], and expression of
BMP in the bovine ovary has been extensively studied
[17-19]. Abundance of specific mRNA transcripts during
oocyte maturation and early embryonic development is
under complex regulation and influenced by post tran-
scriptional and transcriptional mechanisms in a stage
specific fashion [20]. Results of present studies revealed
unique temporal changes in mRNA abundance for above
BMP examined during oocyte maturation and early em-
bryogenesis (Figure 1). Relative abundance of mRNA for
BMP2 (Figure 1A) and BMP10 (Figure 1B) was increased
in MII oocytes relative to the GV stage (P < 0.05), but
Table 1 Sequence of primers for real time RT-PCR for TGFβ superfamily members and receptors, CDX2 and NANOG
Gene Genbank accession number Primer sequence Size (bp)
BMP2 BC134682 F: 5′-AAGGCCCTTGCTTGTCACTTT-3′ 72
R: 5′-TGCTTGCCGCTTTTCTCTTC-3′
BMP3 XM_587912 F: 5′-ATCTGTGGCTGAGCTGCTTGT-3′ 62
R: 5′-GGAAGGGCTGCCTGAGTCT-3′
BMP7 XM_612246 F: 5′-TGCCACTAGCTCTTCCTGGAA-3′ 65
R: 5′-TGAGAGACCCAGGATCCAGAA-3′
BMP10 XM_583418 F: 5′-CGCCCACGAGCAATTCC-3′ 66
R: 5′-TCCCCAGGTCCGTTGGA-3′
SMAD1 BC116117 F: 5′-CACCATGAACTGAAACCATTGG-3′ 68
R: 5′-GATGCACACCTCCTTCTGCTT-3′
SMAD5 DV821574 F: 5′-GCAACGTTTCCTGATTCTTTCC-3′ 74
R: 5′-GGCGGGTAGGGACTATTTGG-3′
ALK3 NM_001076800 F: 5′-TCAGCGAACTATTGCCAAACAG-3′ 75
R: 5′-CCCATCCACACTTCTCCGTATC-3′
ALK6 NM_001105328 F: 5′-CCCACCCCTCGTCCAAAG-3′ 63
R: 5′-GACCGAGTCTTCTGGACAATGG-3′
ALK2 BC133311 F: 5′-TTGGCCTCATCATTTTGTCTGT-3′ 70
R: 5′-CGGAGAGCAACTCCCAATAGG-3′
ACVR2A NM_174227 F: 5′- CCACAAACCCGCCATATCTC -3′ 185
R: 5′- TAGCACCCTCTAACACCTCTG -3′
ACVR2B NM_174495 F: 5′-GGAGCCATCAACTTCCAGAG-3′ 121
R: 5′-GCATGTACTCATCCACAGGTC-3′
BMPR2 XM_002685492 F: 5′-AACACCACTCAGTCCACCTC-3′ 120
R: 5′-GTCAGCATCCTATATCCAAAGCA-3′
NANOG NM_001025344 F: 5′-AAAGTTACGTGTCCTTGCAAACG-3′ 73
R: 5′-GAGGAGGGAAGAGGAGAGACAGT-3′
CDX2 AM293662 F: 5′-FCGTCTGGAGCTGGAGAAGGA-3′ 70
R: 5′-CGGCCAGTTCGGCTTTC-3′
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dance did not change during meiotic maturation. For
BMP2 and BMP10, mRNA abundance remained ele-
vated in early embryos after fertilization until declining
by the 16C stage (P < 0.05) and remained low in morula
and blastocyst stage embryos (Figure 1A and B). In con-
trast, relative mRNA abundance for BMP3 was transi-
ently elevated (>15 fold) in 2C embryos (P < 0.05) and
did not differ at other time points examined (Figure 1C).
BMP7 mRNA (Figure 1D) was also transiently elevated
at the 2C stage and was lowest at 16C, morula and
blastocyst stages (P < 0.05). Results demonstrate dy-
namic, ligand specific temporal regulation of mRNA
abundance for BMP2, BMP3, BMP7 and BMP10 during
bovine oocyte maturation and early embryogenesis.
The BMPs bind to multiple TGFβ superfamily recep-
tors [16]. Expression of BMP receptors in bovine ovarian
sections and or isolated oocytes has been reportedpreviously [19], but temporal regulation of mRNA abun-
dance for BMP receptors during oocyte maturation and
early embryogenesis is not understood. In the current
study, temporal changes in abundance of mRNA in bo-
vine oocytes and early embryos for the prominent Type
I (ALK3, ALK6, ALK2) and Type II receptors (BMPR2,
ACVR2A, ACVR2B) that bind BMPs was examined
(Figure 2). Abundance of mRNA for ALK3 (Figure 2)
was increased in MII oocytes (relative to GV stage), fur-
ther increased, albeit transiently at the 2C stage, de-
creased in 4C and 8C embryos and further decreased in
16C, morula and blastocyst stage embryos (P < 0.05). In
contrast, ALK6 mRNA (Figure 2B) is elevated at the PN
stage, further increased, albeit transiently at the 2C
stage and decreased at 16C, morula and blastocyst
stages (P < 0.05). ALK2 mRNA (Figure 2C) is transiently
elevated in MII oocytes relative to oocytes collected at























Figure 1 Temporal changes in BMP2 (A), BMP10 (B), BMP3 (C) and BMP7 (D) mRNA abundance during oocyte maturation and early
embryogenesis in vitro. Quantitative real time RT-PCR analysis was performed on samples of germinal vesicle (GV) and metaphase II (MII) stage
oocytes and in vitro derived embryos collected at the pronuclear (PN), 2-cell (2C), 4-cell (4C), 8-cell (8C), 16-cell (16C), morula (MO) and blastocyst
(BL) stages (n = 4 pools of 10 oocytes/embryos per pool). Data were normalized relative to abundance of endogenous control (RPS18) and are
shown as mean ± SEM. Values with different superscripts across timepoints denote significant differences (P < 0.05).
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II receptors, BMPR2 (Figure 2D) is increased in MII oo-
cytes relative to GV stage, further increased post
fertilization through the 4C stage and subsequently de-
clines through 16C stage (P < 0.05). While mRNA for
ACVR2B (Figure 2E) but not ACVR2A (Figure 2F) was
increased in MII oocytes relative to GV stage, mRNA
for both ACVR2B and ACVR2A was elevated at PN
stage and remained elevated through the 16C stage,
and was further reduced at morula and blastocyst
stages (P < 0.05; Figure 2E and F). Observed temporal
regulation of type I and Type II BMP receptor
mRNAs supports a potential intrinsic role for BMPs
in meiotic maturation and early embryogenesis.
Signal transduction by members of the TGFβ super-
family is mediated primarily by the SMAD pathways,
with BMP signal transduction linked to SMAD1,
SMAD5 and SMAD8 [16]. Thus changes in mRNA for
BMP receptor associated SMADs during oocyte matur-
ation and early embryogenesis were also investigated
(Figure 3). Messenger RNA for SMAD8 was undetect-
able in bovine oocytes and early embryos. Messenger
RNA for SMAD1 (Figure 3A) and SMAD5 (Figure 3B)
were increased in MII oocytes relative to GV stage (P <
0.05). For SMAD1, mRNA remained elevated after
fertilization until the 4C stage and was further decreased
in 16C, morula and blastocyst stage embryos (P < 0.05;
Figure 3A). For SMAD5, mRNA was further increased
after fertilization at PN, 2C and 4C stages and lowest at
16C, morula and blastocyst stages (P < 0.05; Figure 3B).Effect of embryo culture in the presence of the
transcriptional inhibitor α-amanitin on BMP, BMP receptor
and SMAD1 and SMAD5 mRNA abundance
Messenger RNA transcript adenylation and deadenyla-
tion are prominent mechanisms of regulation of mRNA
abundance during oocyte maturation and early develop-
ment until initiation of embryonic genome activation
[20,21]. Given abundance of above BMP, BMP type I re-
ceptor and SMAD transcripts was elevated in early em-
bryos prior to or through the 8C stage, studies were
done to determine the source (maternal versus embry-
onic) of BMP2, BMP3, BMP7, BMP10, SMAD1, SMAD5,
ALK2, ALK3 and ALK6, transcripts detected in early bo-
vine embryos. When presumptive zygotes were treated
with 50 μg/ml of the RNA polymerase II inhibitor α-
amanitin for 72 h, relative abundance of mRNA for all
BMP system components examined was increased at the
8C stage compared to control embryos (Table 2). Results
suggest that such transcripts present in early embryos at
8C stage are maternal in origin and that post transcrip-
tional regulation of mRNA abundance for such genes
may in fact be transcription dependent. Furthermore ele-
vated transcript abundance was observed when reverse
transcription of mRNA was conducted using oligo dT
primers and not when random hexamers were utilized
(Table 2), suggesting that transcript deadenylation may
help contribute to the stage specific decrease in tran-
script abundance for BMP, BMP receptors and their re-
ceptor associated SMAD in the current studies. Since
























Figure 2 Temporal changes in ALK3 (A), ALK6 (B), ALK2 (C) BMPR2 (D), ACVR2B (E) and ACVR2A (F) mRNA abundance during oocyte
maturation and early embryogenesis in vitro. Quantitative real time RT-PCR analysis was performed on samples of germinal vesicle (GV) and
metaphase II (MII) stage oocytes and in vitro derived embryos collected at the pronuclear (PN), 2-cell (2C), 4-cell (4C), 8-cell (8C), 16-cell (16C),
morula (MO) and blastocyst (BL) stages (n = 4 pools of 10 oocytes/embryos per pool). Data were normalized relative to abundance of endogenous
control (RPS18) and are shown as mean ± SEM. Values with different superscripts across time points denote significant differences (P < 0.05).
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that down regulation of above transcripts may be im-
portant during stages of embryo development after em-
bryonic genome activation.
Effect of BMP 2 supplementation on embryo
development and trophectoderm and inner cell mass
marker mRNA abundance in resulting blastocysts
Previous studies demonstrated a positive association of
oocyte follistatin expression with developmental compe-
tence [2] and potent embryotrophic actions of follistatin
during early embryogenesis including enhanced propor-
tion of embryos cleaving early, increased numbers of
embryos developing to the blastocyst stage, and elevated
mRNA for the TE cell marker CDX2 in resulting blasto-
cysts [3]. Classical actions of follistatin are commonly at-
tributed to high affinity binding and inhibition of activity
of the TGFβ superfamily member activin [5]. However,
previous studies showed stimulatory effects of activin
treatment on rates of early cleavage and blastocystdevelopment, suggesting that actions of follistatin on bo-
vine embryos are likely nonclassical [3]. However, follis-
tatin can also bind at a lower affinity and inhibit activity
of BMPs [7,17]. The current studies demonstrated dy-
namic temporal changes in maternal mRNA for several
BMP, type I and II BMP receptors and their receptor as-
sociated SMADs in bovine embryos prior to genome ac-
tivation. Therefore to further elucidate the potential role
of BMPs in bovine early embryogenesis, effects of BMP2
supplementation during first 72 h of in vitro embryo cul-
ture (through 8C-16C stage) on above developmental
endpoints were investigated. The addition of 1, 10 or
100 ng/ml of recombinant human BMP2 did not alter
percentage of early cleaving embryos, total cleavage
rates, percent embryos developing to 8C-16C stage or
blastocyst rate (Figure 4A-D). However supplementation
with 100 ng/ml of BMP2 increased mRNA for the TE
marker CDX2 and the ICM marker NANOG relative to
embryos cultured without BMP2 (Figure 4E-F). Thus,






















Figure 3 Temporal changes in SMAD1 (A) and SMAD5 (B) mRNA abundance during oocyte maturation and early embryogenesis
in vitro. Quantitative real time RT-PCR analysis was performed on samples of germinal vesicle (GV) and metaphase II (MII) stage oocytes and
in vitro derived embryos collected at the pronuclear (PN), 2-cell (2C), 4-cell (4C), 8-cell (8C), 16-cell (16C), morula (MO) and blastocyst (BL) stages
(n = 4 pools of 10 oocytes/embryos per pool). Data were normalized relative to abundance of endogenous control (RPS18) and are shown as
mean ± SEM. Values with different superscripts across time points denote significant differences (P < 0.05).
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by numbers of embryos reaching a transferable
(blastocyst stage), BMP2 treatment did however impact
characteristics of resulting blastocysts as measured by
abundance of mRNA for CDX2 and NANOG. These re-
sults are in contrast to results obtained following treat-
ment with exogenous follistatin [3] whereby stimulatory
effects on CDX2 mRNA, but not NANOG mRNA were
observed and suggesting biological actions of follistatin
on blastocyst cell allocation are manifest specifically on
the TE lineage.
A growing body of evidence suggests that oocyte
secreted factors can enhance oocyte developmental
competence and embryo developmental progression
[14,15,23]. Our previous studies support a role for en-
dogenous, oocyte-derived follistatin in promoting bovine
embryo developmental progression and cell allocation to
the TE lineage [3]. Results were obtained with follistatin
treatment during initial stages of embryo culture (d 1–3)
up to embryonic genome activation. To our knowledge,
effects of exogenous BMP2 treatment during culture of
bovine embryos have not been previously reported.
Addition of BMP2 or BMP4 during in vitro maturationTable 2 Effects of α-Amanitin treatment on mRNA abundance
Gene RT with oligo dT
Control α-Amanitin treate
SMAD1 1.15 ± 0.27a 9.08 ± 1.19b
SMAD5 1.17 ± 0.35a 7.33 ± 1.27b
BMP2 1.10 ± 0.27a 3.19 ± 0.76b
BMP3 1.02 ± 0.11a 2.85 ± 0.60b
BMP7 1.02 ± 0.12a 3.36 ± 0.66b
BMP10 1.04 ± 0.19a 3.82 ± 0.25b
ALK3 1.23 ± 0.37a 9.41 ± 0.72b
ALK6 1.12 ± 0.25a 5.43 ± 0.71b
ALK2 1.27 ± 0.50a 5.73 ± 1.34b
Note. Different letters (a and b) represent significantly different value (P≤0.05).did not impact rates of meiotic maturation and cumulus
expansion or rates of embryonic development to blasto-
cyst stage following in vitro fertilization [19]. However,
evidence supports a role for oocyte-derived GDF9 and
BMP15 in promoting oocyte developmental competence
as addition of these growth factors exogenously during
in vitro maturation can enhance rates of development to
the blastocyst stage and blastocyst cell allocation to TE
[14,15]. Thus, levels of endogenous BMP2 available dur-
ing in vitro maturation and embryo culture may not be
limiting to embryo developmental capacity in vitro as
reflected by rates of development to the blastocyst stage.
However, the current studies do demonstrate that bovine
embryos can respond to BMP2 stimulation during initial
3 d of culture in vitro with an increase in blastocyst
mRNA for NANOG and CDX2 measured 4 d later and
demonstrate effects of BMP2 treatment on indices of cell
allocation mediated well after treatment administration.
The mechanisms responsible for increased blastocyst
NANOG and CDX2 mRNA in response to BMP2 stimu-
lation are not known. However, BMP4 mediated induc-
tion of CDX2 mRNA expression [24] and promoter
activity [25] have been described in other cell lines andin bovine 8C embryos
RT with random hexamers
d Control α-Amanitin treated
1.03 ± 0.16 1.77 ± 0.17
1.02 ± 0.12 1.45 ± 0.17
1.25 ± 0.49 1.30 ± 0.21
1.15 ± 0.36 3.26 ± 0.88
1.17 ± 0.40 2.96 ± 1.31
1.07 ± 0.23 1.59 ± 0.31
1.06 ± 0.22 1.42 ± 0.31
1.05 ± 0.20 1.38 ± 0.16




Figure 4 BMP2 regulation of bovine early embryonic development. Effects of exogenous BMP2 treatment (0, 1, 10, 100 ng/ml) during first
72 h of in vitro embryo culture. (n = 30 embryos/treatment; n = 4 replicates) on proportion of early cleaving embryos that reached the two-cell
stage within 30 hours post insemination (hpi) (A), total cleavage rate (determined 48 hpi) (B), rates of development to 8- to 16-cell stage
(determined 72 hpi) (C) d7 blastocyst rates (D) and blastocyst mRNA abundance for NANOG (E) and CDX2 (F). Data are shown as mean ± SEM.
Values with different superscripts across treatments indicate significant differences (P < 0.05).
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BMP4 is mediated via SMAD1/5 [16]. However, SMAD2/
3 pathways are linked to NANOG promoter regulation in
embryonic stem cells and antagonistic to BMP signaling
and differentiation to TE fate [26]. While the addition of
BMP2 had no effect on the proportion of embryos that
cleaved early or developed to the 16C or blastocyst stages,
the highest dose of BMP2 did increase both NANOG and
CDX2 mRNA compared to control embryos at the blasto-
cysts stage. NANOG is a marker of the ICM of the blasto-
cysts and is important for maintaining pluripotency of the
cells in the ICM [27]. In contrast CDX2 is a marker for
TE cells and is in fact required for the establishment of
the TE in the blastocysts of mice and cattle [28,29].
NANOG and CDX2 also cross regulate each other to pro-
mote proper blastocyst formation [30]. As BMP2 supple-
mentation increases mRNA for both markers it is possible
that BMP2 enhances the differentiation of the two cell
types, rather than promoting one cell type over the other.Conclusions
In summary, results of present studies demonstrate pro-
nounced temporal regulation of mRNA for select BMP
ligands, type I and II receptors and cognate intracellular
signaling molecules during bovine early embryonic de-
velopment. This study was limited in that it only exam-
ined changes in abundance rather than accompanying
changes in protein abundance. However, to our know-
ledge, temporal changes in abundance of mRNA for spe-
cific BMP including BMP2, BMP3, BMP7 and BMP10 at
specific stages of bovine early embryonic development
have not been examined previously. While stimulatory
effects of BMP2 on early cleavage and development to
8C to 16C and blastocyst stages were not noted in re-
sponse to BMP2 supplementation of culture media (at
doses tested) during first 72 h of development, increased
mRNA for CDX2 and NANOG was detected in resulting
blastocysts, demonstrating a functional BMP2 signaling
system in early bovine embryos. Furthermore, distinct
Lee et al. Reproductive Biology and Endocrinology 2014, 12:67 Page 9 of 10
http://www.rbej.com/content/12/1/67results observed in present studies suggest that embryo-
trophic actions of follistatin reported in previous studies
[3] likely are not linked to inhibition of endogenous
BMP2 activity.
Additional file
Additional file 1: Figure S1. Temporal changes in RPS18 mRNA during
oocyte maturation and early embryogenesis in vitro. Quantitative real
time RT-PCR analysis was performed on samples of germinal vesicle (GV)
and metaphase II (MII) stage oocytes and in vitro derived embryos
collected at the pronuclear (PN), 2-cell (2C), 4-cell (4C), 8-cell (8C), 16-cell
(16C), morula (MO) and blastocyst (BL) stages (n = 4 pools of 10 oocytes/
embryos per pool). Data are shown as mean ± SEM. Values with different
superscripts across time points denote significant differences (P < 0.05).
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